Neuropace, Inc. NPCE Change in Deferred Revenue
Change in Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s change in deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s change in deferred revenue?
- Neuropace, Inc. (NPCE) reported change in deferred revenue of -$15K in Q1 2026.
- How has Neuropace, Inc.'s change in deferred revenue changed year-over-year?
- Neuropace, Inc.'s change in deferred revenue decreased by 112.1% year-over-year, from $124K to -$15K.
- What is the long-term trend for Neuropace, Inc.'s change in deferred revenue?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s change in deferred revenue has grown at a -7.5% compound annual growth rate (CAGR), from -$566K to -$414K.
- What does change in deferred revenue mean?
- Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.